Dr. Reddys Laboratories Ltd.

Dr Reddys Laboratories has reported results for its first quarter ended June 30, 2011.

The company’s net profit for the quarter has surged by 25.38% at Rs 262.74 crore as compared to Rs 209.55 crore for the quarter ended June 30, 2010. Its net income from sales and services has increased by 17.54% to Rs 1978.32 crore for the quarter under review from Rs 1683.13 crore for the corresponding quarter of the previous year.

Dr Reddys, a global pharmaceutical company, has a global presence in more than 100 countries, with subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries and third-party distribution set ups in 21 countries.